Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Demand for Treatment Syndromes Dementia Movement Disorders Market from Major End-use Sectors to Increase in the Near Future


According to a new market report published by Persistence Market Research “Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders: Asia to Witness Highest Growth by 2020,” the global treatment for syndromes of dementia and movement disorders market was valued at USD 12,859.8 million in 2014 and is expected to grow at a CAGR of 8.6% from 2014 to 2020, to reach an estimated value of USD 21,154.8 million in 2020.

The treatment for syndromes of dementia and movement disorders market is witnessing significant growth due to increasing R&D investments in drug discovery and developments. In addition, increasing prevalence of neurodegenerative disorders and rising awareness about mental disorders are also driving the growth of the market. However, most of the drugs fail in Phase III due to lack of sufficient knowledge about the mechanisms of the brain and the unknown causes of the disease.

Want Insights To Treatment Syndromes Dementia Movement Disorders Market? Ask For Sample!

Get A Customized Scope To Match Your Need Ask An Expert –

Some of the major players in the treatment for syndromes of dementia and movement disorders market:

  • Hoffmann-La Roche, Ltd.
  • Novartis AG.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Valeant Pharmaceutical International, Inc.
  • AstraZeneca GmbH and Pfizer, Inc.

In addition, lack of comprehensive therapeutic management, strict regulations, and time-consuming drug approval process inhibit the growth of the market. The global treatment for syndromes of dementia and movement disorders market is anticipated to grow from an estimated USD 12,859.8 million in 2014 to USD 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period.

In North America, growing aging population and rising incidence of neurodegenerative disease are driving the use of treatment for syndromes of dementia and movement disorders in the market. In addition, lack of proper medication is also fuelling the growth of treatments for syndromes of dementia and movement disorders market.

How About Knowing The Product/Technology Driving The Treatment Syndromes Dementia Movement Disorders Market Before Investing Therein? Click The “Purchase Now” Button Of Our Treatment Syndromes Dementia Movement Disorders Market Report!

In Europe, the treatment for syndromes of dementia and movement disorders market is driven by rising incidence of mental disorder related disease and growing aging population. On the other hand, various awareness programs were launched by public and private health institutions to control dementia and movement disorders, which would increase the use of dementia and movement disorder drugs in the region.

However, in Asia the growth for treatment for syndromes of dementia and movement disorders is much higher than developed countries due to widening health insurance penetration, and large population base.

Read More Trending “PMR Exclusive Article”-

Bile Duct Cancer (Cholangiocarcinoma) Treatment MarketBile Duct Cancer (Cholangiocarcinoma) Treatment Market Segmented By Gemcitabine Combination Therapy, 5-fluorouracil Combination Therapy, Capecitabine Combination Therapy, Gemcitabine Single Agent Treatment with Radiation Therapy, Surgery Services Spending

Bone Mineral Densitometry (BMD) MarketBone Mineral Densitometry (BMD) Market Segmented By Axial Bone Mineral Densitometry, Peripheral Bone Mineral Densitometry Product with Dual Energy X-Ray Absorptiometry, Peripheral Dual Energy X-Ray Absorptiometry, Quantitative Ultrasound Technology

About Us: – Persistence Market Research

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –


Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts